Synthetic Cannabinoids (K2 / Spice)
'Synthetic cannabinoids' covers two very different things. First, the K2/Spice class of research-chemical cannabinoids (e.g. AMB-FUBINACA) sprayed on plant material — far more dangerous than cannabis, causing seizures, psychosis, and death, and largely Schedule I. Second, hemp-synthesized cannabinoids like delta-8/HHC — milder but in flux under a 2025 law effective November 12, 2026. This page covers both, separately.
Overview
The term 'synthetic cannabinoids' is used for two distinct groups that should not be confused. GROUP 1 — the K2/Spice class: laboratory-designed chemicals (such as the JWH series and AMB-FUBINACA) that act on cannabinoid receptors far more powerfully than cannabis, sprayed onto dried plant material and smoked, or sold as liquids. These are dangerous novel psychoactive substances, not 'fake weed' in any benign sense. GROUP 2 — hemp-derived synthesized cannabinoids: compounds like delta-8 THC and HHC, chemically converted from hemp CBD and sold as legal-alternative products. This page addresses both, but they differ enormously in danger and legal status.
Source: DEA; peer-reviewed literature (NIH/PMC); Congress.gov (CRS)
Chemistry & mechanism of action
Both groups act on the CB1 cannabinoid receptor, but very differently. GROUP 1 (K2/Spice): most are full agonists at CB1 and bind far more strongly than THC (a partial agonist), which is why their effects are so much more intense and unpredictable — there is no natural ceiling, and toxic reactions are common. GROUP 2 (hemp-synthesized, delta-8/HHC): also CB1 agonists, but with intoxication broadly in the range of, or milder than, delta-9 THC. The extreme receptor activation of Group 1 is the core reason it is so much more dangerous than either cannabis or Group 2.
Source: peer-reviewed literature (NIH/PMC); DEA
Effects
GROUP 1 (K2/Spice) effects are erratic and often severe: beyond a cannabis-like high, users experience extreme anxiety, agitation, hallucinations, vomiting, rapid heart rate, seizures, and loss of consciousness — reactions far removed from cannabis. GROUP 2 (delta-8/HHC) effects resemble a milder-to-comparable THC high with the usual dry mouth, red eyes, and impaired coordination. The gulf between the two groups is the single most important thing to understand about products labeled 'synthetic cannabinoids'.
Source: peer-reviewed literature (NIH/PMC); DEA
Risks & harms
The two groups carry very different dangers and must be judged separately. GROUP 1 (K2/Spice) is genuinely high-harm: because these are full, potent CB1 agonists with no natural ceiling, they cause severe toxicity that cannabis does not — seizures, psychosis, dangerous heart-rhythm and blood-pressure changes, acute kidney injury, and deaths, including mass-poisoning clusters when a batch is unusually strong or laced. Some batches have been contaminated with other dangerous substances, and potency varies wildly across and within products, so there is no reliable dose. GROUP 2 (delta-8/HHC and similar hemp-synthesized cannabinoids) carries THC-like risks — anxiety, paranoia, rapid heart rate, over-intoxication (especially edibles), pediatric poisoning from candy-like packaging — plus manufacturing contaminants and mislabeled potency, but not the extreme acute lethality associated with Group 1. For any of these, product content and purity cannot be assumed. If someone has a seizure, chest pain, severe agitation or psychosis, cannot be roused, or a child has ingested a product, call 911 immediately, and Poison Control at 1-800-222-1222 can advise. This page has not yet been medically reviewed.
Source: DEA; SAMHSA; peer-reviewed literature (NIH/PMC)
Legal status (US)
US legal status differs sharply between the two groups. GROUP 1 (K2/Spice): many of these chemicals are explicitly Schedule I controlled substances, the DEA has scheduled numerous ones by name and class, and unlisted ones can be prosecuted under the Federal Analogue Act — this class has long been illegal. GROUP 2 (hemp-synthesized delta-8/HHC): these occupied the post-2018-Farm-Bill gray area, but a 2025 federal law (P.L. 119-37) redefines 'hemp' by total THC and excludes cannabinoids synthesized or manufactured outside the plant; effective November 12, 2026 it is expected to make most such products federally illegal. Because Group 2's status is mid-transition, verify current federal and state law. This page has not yet been medically reviewed.
Source: DEA; US federal law (Controlled Substances Act; Federal Analogue Act; 2018 Farm Bill; P.L. 119-37, eff. 2026-11-12); Congress.gov (CRS)
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling — penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authorityand your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulatein the destination immediately — notthe destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With cannabis, anxiety or a racing heart usually pass with time. Sit somewhere calm, sip water, and rest — strong edibles in particular can take hours to ease.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown — pending review”Identity
- PubChem CID
- N/A — no single PubChem compound (mixture/class/plant/concept)
- IUPAC name
- N/A — no single PubChem compound (mixture/class/plant/concept)
- Molecular formula
- N/A — no single PubChem compound (mixture/class/plant/concept)
- SMILES
- N/A — no single PubChem compound (mixture/class/plant/concept)
- InChIKey
- N/A — no single PubChem compound (mixture/class/plant/concept)
- Synonyms / aliases
- k2, spice
Composition
- Composition
- Unknown — pending review (no single compound; needs an epidemiology / composition source)
Physical / pill characteristics
- Dosage form
- Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
- Route
- Unknown — pending review
- Shape
- Unknown — pending review
- Color
- Unknown — pending review
- Imprint
- Unknown — pending review
- Score
- Unknown — pending review
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- Unknown — pending review
Dosage
Pending medical reviewer
